Interactions between growth factors and integrins: Latent forms of transforming growth factor-β are ligands for the integrin αvβ1

Molecular Biology of the Cell

Volumn 9, Issue 9, 1998, Pages 2627-2638

  Munger, John S ^a   Harpel, John G ^a   Giancotti, Filippo G ^b   Rifkin, Daniel B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BINDING PROTEIN; DIMER; FIBRONECTIN; GENE PRODUCT; INTEGRIN; LATENCY ASSOCIATED PEPTIDE; LIGAND; MANGANESE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CELL SPREADING; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0031670654     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.9.2627     Document Type: Article

References (42)

1. Akiyama, S.K., Yamada, S.S., Chen, W.T., and Yamada, K.M. (1989). Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 109, 863-875.
2. Balzac, F., Retta, S.F., Albini, A., Melchiorri, A., Koteliansky, V.E., Geuna, M., Silengo, L., and Tarone, G. (1994). Expression of beta1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility. J. Cell Biol. 127, 557-565.
3. Bodary, S.C., and McLean, J.W. (1990). The integrin β1 subunit associates with the vitronectin receptor αv subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J. Biol. Chem. 265, 5938-5941.
4. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85, 683-693.
5. Dallas, S.L., Miyazono, K., Skerry, T.M., Mundy, G.R., and Bonewald, L.F. (1995). Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural protein. J. Cell Biol. 131, 539-549.
6. Dennis, P.A., and Rifkin, D.B. (1991). Cellular activation of latent transforming growth factor-β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88, 580-584.
7. Falcioni, R., Cimino, L., Gentileschi, M.P., D'Agnano, I., Zupi, G., Kennel, S.J., and Sacchi, A. (1994). Expression of β1, β3, β4, and β5 integrins by human lung carcinoma cells of different histiotypes. Exp. Cell Res. 210, 113-122.
8. Flaumenhaft, R., Abe, M., Sato, Y., Miyazono, K., Harpel, J., Heldin, C.-H., and Rifkin, D.B. (1993). Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J. Cell Biol. 120, 995-1002.
9. Gailit, J., and Ruoslahti, E. (1988). Regulation of the fibronectin receptor affinity by divalent cations. J. Biol. Chem. 263, 12927-12933.
10. Giancotti, F.G. (1997). Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr. Opin. Cell Biol. 9, 691-700.
11. Grainger, D.J., Wakefield, L., Bethell, H.W., Farndale, R.W., and Metcalfe, J.C. (1995). Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat. Med. 1, 932-937.
12. Hildebrand, A., Romaris, M., Rasmussen, L.M., Heinegard, D., Twardzik, D.R., Border, W.A., and Ruoslahti, E. (1994). Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β. Biochem. J. 302, 527-534.
13. Hu, D.D., Lin, E.C.K., Kovach, N.L., Hoyer, J.R., and Smith, J.W. (1995). A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5. J. Biol. Chem. 270, 26232-26238.
14. Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25.
15. Ignotz, R.A., and Massague, J. (1986). Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337-4345.
16. Ignotz, R.A., and Massague, J. (1987). Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell. 51, 189-197.
17. Jones, J.I., Gockerman, A., Busby, W.H.J., Wright, G., and Clemmons, D.R. (1993). Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90, 10553-10557.
18. Kirchhofer, D., Grzesiak, J., and Pierschbacher, M.D. (1991). Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J. Biol. Chem. 266, 4471-4477.
19. Klein, S., Giancotti, F.G., Presta, M., Albelda, S.M., Buck, C.A., and Rifkin, D.B. (1993). Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell 4, 973-982.
20. Kojima, S., Nara, K., and Rifkin, D.B. (1993). Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol. 121, 439-448.
21. Massague, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
22. McCaffrey, T.A., Falcone, D.J., Vicente, D., Du, B., Consigli, S., and Borth, W. (1994). Protection of transforming growth factor-β1 activity by heparin and fucoidan. J. Cell. Physiol. 159, 51-59.
23. McMahon, G.A., Dignam, J.D., and Gentry, L.E. (1996). Structural characterization of the latent complex between transforming growth factor-β1 and β1-latency-associated peptide. Biochem. J. 313, 343-351.
24. Munger, J.S., Harpel, J.G., Gleizes, P., Mazzieri, R., Nunes, I., and Rifkin, D.B. (1997). Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int. 51, 1376-1382.
25. Nesbitt, S., Nesbit, A., Helfrich, M., and Horton, M. (1993). Biochemical characterization of human osteoclast integrins. Osteoclasts express αvβ3, α2β1 and αvβ1 integrins. J. Biol. Chem. 268, 16737-16745.
26. Nunes, I., Gleizes, P.E., Metz, C.N., and Rifkin, D.B. (1997). Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 136, 1151-1163.
27. Pierschbacher, M.D., and Ruoslahti, E. (1984). Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309, 30-33.
28. Pytela, R., Pierschbacher, M.D., Argraves, S., Suzuki, S., and Ruoslahti, E. (1987). Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol. 144, 475-489.
29. Pytela, R., Pierschbacher, M.D., and Ruoslahti, E. (1985). Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40, 191-198.
30. Rusnati, M., Tanghetti, E., Dell'Era, P., Gualandris, A., and Presta, M. (1997). αvβ3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol. Biol. Cell 8, 2449-2461.
31. Schultz-Cherry, S., and Murphy-Ullrich, J.E. (1993). Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122, 923-932.
32. Taipale, J., and Keski-Oja, J. (1997). Growth factors in the extracellular matrix. FASEB J. 11, 51-59.
33. Taipale, J., Miyazono, K., Heldin, C.H., and Keski-Oja, J. (1994). Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol. 124, 171-181.
34. Taipale, J., Saharinen, J., Hedman, K., and Keski-Oja, J. (1996). Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44, 875-889.
35. Takeuchi, Y., Kodama, Y., and Matsumoto, T. (1994). Bone matrix decorin binds transforming growth factor-β and enhances its bio-activity. J. Biol. Chem. 269, 32634-32638.
36. Todaro, G.J., Fryling, C., and DeLarco, J.E. (1980). Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 77, 5258-5262.
37. Vogel, B.E., Tarone, G., Giancotti, F.G., Gailit, J., and Ruoslahti, E. (1990). A novel fibronectin receptor with an unexpected subunit composition (αvβ1). J. Biol. Chem. 265, 5934-5937.
38. Weinacker, A., Chen, A., Agrez, M., Cone, R.I., Nishimura, S., Wayner, E., Pytela, R., and Sheppard, D. (1994). Role of the integrin αvβ6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J. Biol. Chem. 269, 6940-6948.
39. Yamaguchi, Y., Mann, D.M., and Ruoslahti, E. (1990). Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346, 281-284.
40. Yang, Y., Dignam, J.D., and Gentry, L.E. (1997). Role of carbohydrate structures in the binding of β1-latency-associated peptide to ligands. Biochemistry 36, 11923-11932.
41. Zhang, Z., Morla, A.O., Vuori, K., Bauer, J.S., Juliano, R.L., and Ruoslahti, E. (1993). The αvβ1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J. Cell Biol. 122, 235-242.
42. Zhang, Z., Vuori, K., Reed, J.C., and Ruoslahti, E. (1995). The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 92, 6161-6165